ConductScience.org, home
Cell lines
API referenceFor AI assistants

Cell line · CVCL_0092

NALM-6

Cancer cell line, Homo sapiens. Adult B acute lymphoblastic leukemia. 99 papers.

4 sourcescell-lines-2026-11-14-0.1.0

Download JSON
Cite this record

ConductScience Library. NALM-6. Cell lines, record CVCL_0092. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_0092

On this page

Cell line

As Cellosaurus gives it.

Name
NALM-6
Accession
CVCL_0092
RRID
RRID:CVCL_0092
Synonyms
Nalm-6, NALM 6, Nalm 6, NALM6, Nalm6, NALM-6-M1
Species
Homo sapiens (Human)
Sex
Male
Age at sampling
19Y
Category
Cancer cell line
Diseases
Adult B acute lymphoblastic leukemia (NCIt C9143); Precursor B-cell acute lymphoblastic leukemia (ORDO Orphanet_99860)
Derived from
Peripheral blood (in situ)
Entry created
2012-04-04
Entry updated
2026-06-25

Source Cellosaurus

Problems0

Cellosaurus records no problem for this cell line.

None in this release.

Papers99

PaperJournalYearHow we knowRetractedSource
ETV6 Rearrangement Suppresses CDKN1B Transcription by Disrupting an Intragenic Super-enhancer in Acute Lymphoblastic Leukemia.Cancer Res2026Its Methods give the RRID and name the linePubMed
FATP2-mediated lipid metabolism enhances chimeric antigen receptor T-cell therapy resistance in B-cell acute lymphoblastic leukemia.Leukemia2026Its Methods give the RRID and name the linePubMed
Leukemia risk factor ARID5B coordinates HDAC-mediated transcriptional repression.Nucleic Acids Res2026Its Methods give the RRID and name the linePubMed
Characterization of CAR-T cell factors that contribute to myeloid cell activation.Gene Ther2026Its Methods give the RRID and name the linePubMed
Low-Strength Type I Interferon Signaling Promotes CAR T-cell Treatment Efficacy.Cancer Immunol Res2026Its Methods give the RRID and name the linePubMed
Mitochondrial ETF insufficiency drives neoplastic growth by selectively optimizing cancer bioenergetics.Elife2026Its Methods give the RRID and name the linePubMed
Engineering functionality-optimized fully human B7-H3 CAR T cells for enhanced solid tumor therapy.Cell Rep Med2026Its Methods give the RRID and name the linePubMed
Development of CAR T Cells Targeting a Surface RNA-Binding Protein for the Treatment of Acute Leukemias.Cancer Discov2026Its Methods give the RRID and name the linePubMed
Dual-antigen recognition iPSC-derived CAR-T cells for B-cell malignancies: establishment of a COVID-19 vaccine synergy strategy.Front Cell Dev Biol2026Its Methods give the RRID and name the linePubMed
Exploring the Role of Environmental Factors on Chromosomal Translocations Associated With Childhood Leukaemia.Cancer Med2026Its Methods give the RRID and name the linePubMed

1 to 10 of 99

See all 99 papers

Relatives41

RelationCell lineAccessionProblemSource
Derived from itBLIN-1CVCL_8173Has a recorded problemCell lines
Derived from itHyCyte NALM-6 stable cell line for hP4HA2 overexpressionCVCL_F4RLCell lines
Derived from itHyCyte NALM-6 stable cell line for hZCCHC7 overexpressionCVCL_F4S8Cell lines
Derived from itLR10.6CVCL_8260Has a recorded problemCell lines
Derived from itN6-1000CVCL_UJ07Cell lines
Derived from itN6-500CVCL_UJ08Cell lines
Derived from itN6-KU70-2-DGCVCL_C4PECell lines
Derived from itN6/ADRCVCL_UJ06Cell lines
Derived from itNALM-6 DCLRE1C(-/-)CVCL_HE04Cell lines
Derived from itNALM-6 LIG4(-/-)CVCL_HE05Cell lines

1 to 10 of 41

See all 41 relatives

Cell banks7

Cell bankCatalog numberStatusSource
AddexBioC0003030/5015Cellosaurus
CLS300297CLS
DSMZACC-128DSMZ
HysigenTCH-C422Hysigen
NCBI_IranC212Cellosaurus
RCBRCB1933RCB
TKGTKG 0413Cellosaurus

Data dates

The date of each source this release read.

Cellosaurus
2026-10-22
Cellosaurus
PubMed Central's articles
2026-11-12
PubMed Central's articles
Our copy of PubMed
2026-11-06
Our copy of PubMed

Sources 4

  • CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
  • PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
  • NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
  • PubMedNLM's terms
Each source's terms
  • CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
  • PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
  • NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
  • PubMedNLM's terms

Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.

For software

Read this cell line from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/cell-lines/v1/CVCL_0092

GET https://conductscience.org/api/cell-lines/v1/CVCL_0092/papers?page=2

API referenceFor AI assistants